methyleugenol has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gong, N; Hou, S; Kuang, B; Li, Q; Sun, K; Wang, M; Wang, MMZ; Zhang, J | 1 |
El-Shorbagy, HM; Saleh, H | 1 |
Cho, GS; Choi, YK; Hwang, S; Kim, BW; Kim, HC; Kim, WK; Kim, YS; Lee, JC; Lim, JH | 1 |
3 other study(ies) available for methyleugenol and Disease Models, Animal
Article | Year |
---|---|
Methyl eugenol attenuates liver ischemia reperfusion injury via activating PI3K/Akt signaling.
Topics: Animals; Cell Line; Chromones; Disease Models, Animal; Eugenol; Hepatocytes; Humans; Liver; Male; Mice; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Signal Transduction; Warm Ischemia | 2021 |
Mechanism underlying methyl eugenol attenuation of intestinal ischemia/reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Disease Models, Animal; Eugenol; Inflammation Mediators; Interleukin-6; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Oxidative Stress; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Methyleugenol reduces cerebral ischemic injury by suppression of oxidative injury and inflammation.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cells, Cultured; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Eugenol; Free Radicals; Glucose; Inflammation; Male; Neurons; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Superoxides | 2010 |